期刊文献+

塞来昔布对急性肺损伤大鼠外周血IL-8和MCP-1的作用研究 被引量:1

Effect of celecoxib on the expression of IL-8 and MCP-1 in peripheral blood of rats with acute lung injury
下载PDF
导出
摘要 目的探讨脂多糖(lipopolysaccharide,LPS)所致大鼠急性肺损伤时环氧合酶(COX)-2抑制剂塞来昔布对外周血趋化因子白细胞介素(interlukine,IL)-8和单核细胞趋化蛋白(monocyte chemoattractant protein,MCP)-1表达的影响。方法 45只大鼠随机分为3组:对照组(n=15),给予等量的0.9%氯化钠溶液;LPS组(n=15):尾静脉注射LPS(5 mg/kg)复制急性肺损伤模型;塞来昔布治疗组(n=15):注射LPS复制急性肺损伤模型后30 min塞来昔布灌胃(20 mg/kg),于3 h后放血处死动物。采用酶联免疫吸附试验(ELISA)检测3组大鼠外周血IL-8和MCP-1的表达水平。结果 LPS组和对照组相比外周血IL-8和MCP-1的表达差异均有统计学意义(P<0.05);塞来昔布组和LPS组相比,差异有统计学意义(P<0.05)。结论塞来昔布可能通过抑制趋化因子IL-8和MCP-1的表达,改善大鼠急性肺损伤反应程度。 Objective To investigate the effects of celecoxib on the expressions of peripheral blood chemokines-interlukine 8 ( IL-8) and monocyte chemoattractant protein ( MCP-1 ) in rats with acute lung injury induced by lipopolysaccharide ( LPS) .Methods Forty-five rats were randomly divided into three groups:control group,LPS group and celecoxib treatment group ,with 15 rats in each group.The rats in control group were given 0.9%sodium chloride solution ,the animal models with acute lung injury were established by intravenous injection LPS(5 mg/kg) and the rats in celecoxib treatment group were given celecoxib (20mg /kg) at 30min after LPS induction,then the rats were sacrificed after 3h.The expression levels of IL-8 and MCP-1 in peripheral blood of rats were detected by ELISA .Results There were significant differences in the expression levels of IL-8 and MCP-1 between LPS group and control group ( P 〈0.05).There were significant differences in the expression levels of IL-8 and MCP-1 between celecoxib treatment group and LPS group ( P 〈0.05).Conclusion Celecoxib can improve the reaction extent of rats to acute lung injury by inhibiting the expression levels of IL -8 and MCP-1.
出处 《河北医药》 CAS 2013年第21期3207-3208,共2页 Hebei Medical Journal
基金 河北省医学科学研究重点课题(编号:20120026)
关键词 急性肺损伤 趋化因子 白介素-8 单核细胞趋化蛋白-1 塞来昔布 acute lung injury chemokines IL-8 MCP-1 celecoxib
  • 相关文献

参考文献8

  • 1Matthay MA ,Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome : four decades of inquiry into pathogenesis and rational management. Am J Resp Cell Mol Biol,2005,33 : 319-327.
  • 2DAlessio FR,Tsushima K,Aggarwal NR,et al. CD4+ CDs Foxp3 + Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest,2009,119:2898-2913.
  • 3Everts B, Wahrborg P, Hedner T. COX-2-Specific inhibitors-the emer- gence of a new class of analgesic and anti-inflammatory drugs. Clin Rheu- mato1,2000,19 : 331-343.
  • 4Matsuda K, Nakamura S, Matsushita T. Celecoxib inhibits nitric oxide production in ehondrocytes of ligament-damaged osteoarthritic rat joints. Rheumatol Int ,2006,26 : 991-995.
  • 5Roh GS, Yi CO, Cho YJ, et al. Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema. Am J Physiol Lung Cell Mol Physio1,2010 ,299 : L184-191.
  • 6Aggarwal A, Baker CS, Evans TW, et al. G-CSF and IL-8 but not GM- CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur 1Respir J, 2000,15 : 895-901.
  • 7Bao Z, Ye Q, Gong W, et al. Humanized monoclonal antibody against the chemokine CXCL-8 ( IL-8 ) effectively prevents acute lung injury. Int Im- munopharmaco1,2010,10 :259-263.
  • 8Niu J, Kolattukudy PE. Role of MCP-1 in cardiovascular disease: molecu- lar mechanisms and clinical implications. Clin Sci (Lond),2009,117 : 95-109.

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部